You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Accord Hlthcare Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and fifty-four approved drugs.

There are three tentative approvals on ACCORD HLTHCARE drugs.

Summary for Accord Hlthcare

US Patents:	0
Tradenames:	131
Ingredients:	128
NDAs:	154

Drugs and US Patents for Accord Hlthcare

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	FLUOROURACIL	fluorouracil	INJECTABLE;INJECTION	040743-001	Apr 26, 2007	AP	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	PEMETREXED DISODIUM	pemetrexed disodium	POWDER;INTRAVENOUS	203485-003	May 25, 2022	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET;ORAL	212399-004	Oct 19, 2020	AB1,AB2,AB3,AB4	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	LACOSAMIDE	lacosamide	TABLET;ORAL	205011-001	Jul 12, 2022		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	SIMVASTATIN	simvastatin	TABLET;ORAL	078155-001	Feb 26, 2008	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	CLOZAPINE	clozapine	TABLET;ORAL	202873-001	Nov 25, 2015	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	214347-002	Nov 22, 2021		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.